MediciNova, Inc. (TYO:4875)
Japan
· Delayed Price · Currency is JPY MediciNova Statistics
Total Valuation
MediciNova has a market cap or net worth of JPY 9.57 billion. The enterprise value is 4.30 billion.
| Market Cap | 9.57B |
| Enterprise Value | 4.30B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 49.05M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 42.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.57 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.72 |
Financial Position
The company has a current ratio of 17.66, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.66 |
| Quick Ratio | 17.14 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.33% and return on invested capital (ROIC) is -14.39%.
| Return on Equity (ROE) | -20.33% |
| Return on Assets (ROA) | -13.81% |
| Return on Invested Capital (ROIC) | -14.39% |
| Return on Capital Employed (ROCE) | -25.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -128.54M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MediciNova has paid 829,155 in taxes.
| Income Tax | 829,155 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.90% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -13.90% |
| 50-Day Moving Average | 206.50 |
| 200-Day Moving Average | 258.68 |
| Relative Strength Index (RSI) | 36.15 |
| Average Volume (20 Days) | 33,350 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 13.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.91B |
| Pretax Income | -1.67B |
| Net Income | -1.67B |
| EBITDA | -1.90B |
| EBIT | -1.91B |
| Earnings Per Share (EPS) | -34.07 |
Balance Sheet
The company has 5.48 billion in cash and 53.17 million in debt, giving a net cash position of 5.42 billion.
| Cash & Cash Equivalents | 5.48B |
| Total Debt | 53.17M |
| Net Cash | 5.42B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.48B |
| Book Value Per Share | 152.45 |
| Working Capital | 5.32B |
Cash Flow
In the last 12 months, operating cash flow was -1.58 billion and capital expenditures -134,024, giving a free cash flow of -1.58 billion.
| Operating Cash Flow | -1.58B |
| Capital Expenditures | -134,024 |
| Free Cash Flow | -1.58B |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MediciNova does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -17.46% |
| FCF Yield | -16.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 26, 2006. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 26, 2006 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |